WebRock Ventures (WRV) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
NAV decreased 22.0% quarter-over-quarter to SEK 488.2 million, mainly due to the Cardo Health–Vibe transaction.
Webrock exchanged Cardo Health shares for a 44.5% stake in Vibe, valued at SEK 140.6 million.
SEK 76.8 million private placement and Nasdaq First North Growth Market debut in February 2024.
Portfolio companies showed strong operational progress, especially in Brazil's fintech and health tech sectors.
Financial highlights
Operating profit for Jan–Jun 2024 was SEK -157.3 million, compared to SEK -13.4 million in Jan–Jun 2023.
Net profit for the period was SEK -157.3 million (Jan–Jun 2023: SEK -13.4 million).
Profit per share was SEK -7.7, down from SEK -0.8 year-over-year.
Investments during the period totaled SEK 26.1 million, up from SEK 9.1 million year-over-year.
Cash and cash equivalents stood at SEK 18.3 million as of June 30, 2024.
Outlook and guidance
BFG is expected to increase its portfolio weight through 2024.
FinanZero aims to reach break-even by Q4 2024, supported by a SEK 10 million convertible loan.
Vibe will focus on scaling its AI-driven mental health platform, targeting B2B customers.
Latest events from WebRock Ventures
- NAV up 6.1% to 273.7 Mkr, with Lara and Olik delivering strong growth and profitability.WRV
Q4 202520 Feb 2026 - NAV up 1.5% QoQ to SEK 268.5M; Lara and Olik deliver strong growth and profitability.WRV
Q3 202511 Nov 2025 - NAV up 2.0% QoQ to SEK 264.4m, with strong growth from Lara and Olik and improved profitability.WRV
Q2 202526 Aug 2025 - NAV down 1.6% QoQ to SEK 480.3m; FinanZero profitable, Olik revenue up 548% YoY.WRV
Q3 202413 Jun 2025 - Olik's cash flow positivity and FinanZero exit drive renewed focus on core holdings.WRV
Q1 20256 Jun 2025 - NAV down 46% QoQ as Webrock refocuses on BFG, Lara, and Qred for resilient growth.WRV
Q4 20246 Jun 2025